Search research articles
Contact Us
Filters
Showing results (41-50 of 106) with videos related to
Page
of 11
Sort By:
Australian and New Zealand Journal of Medicine
|
October 1, 1975
Decreased capacity to metabolize diphenylhydantoin in a patient with hypersensitivity to warfarin
F Bochner, W D Hooper, M J Eadie, et al.
Clinical and Experimental Neurology
|
January 1, 1978
Preliminary observations on the pharmacokinetics of methylphenobarbitone
M J Eadie, F Bochner, W D Hooper, et al.
Epilepsy Research
|
May 1, 1995
Metabolism of carbamazepine and co-administered anticonvulsants during pregnancy
I Bernus, W D Hooper, R G Dickinson, et al.
British Journal of Clinical Pharmacology
|
July 1, 1997
The mechanism of the carbamazepine-valproate interaction in humans
I Bernus, R G Dickinson, W D Hooper, et al.
Epilepsy Research
|
July 1, 1996
Dose-dependent metabolism of carbamazepine in humans
I Bernus, R G Dickinson, W D Hooper, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1974
Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease
W D Hooper, F Bochner, M J Eadie, et al.
European Journal of Clinical Pharmacology
|
January 1, 1994
Urinary excretion of phenobarbitone and its metabolites in chronically treated patients
I Bernus, R G Dickinson, W D Hooper, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1994
Stereoselective hydroxylation of tacrine in rats and humans
W D Hooper, W F Pool, T F Woolf, et al.
British Journal of Clinical Pharmacology
|
November 1, 1994
Inhibition of phenobarbitone N-glucosidation by valproate
I Bernus, R G Dickinson, W D Hooper, et al.
European Journal of Clinical Pharmacology
|
January 1, 1994
Early stage autoinduction of carbamazepine metabolism in humans
I Bernus, R G Dickinson, W D Hooper, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 106) with videos related to
Sort By:
Page
of 11
Australian and New Zealand Journal of Medicine
|
October 1, 1975
Decreased capacity to metabolize diphenylhydantoin in a patient with hypersensitivity to warfarin
F Bochner, W D Hooper, M J Eadie, et al.
Clinical and Experimental Neurology
|
January 1, 1978
Preliminary observations on the pharmacokinetics of methylphenobarbitone
M J Eadie, F Bochner, W D Hooper, et al.
Epilepsy Research
|
May 1, 1995
Metabolism of carbamazepine and co-administered anticonvulsants during pregnancy
I Bernus, W D Hooper, R G Dickinson, et al.
British Journal of Clinical Pharmacology
|
July 1, 1997
The mechanism of the carbamazepine-valproate interaction in humans
I Bernus, R G Dickinson, W D Hooper, et al.
Epilepsy Research
|
July 1, 1996
Dose-dependent metabolism of carbamazepine in humans
I Bernus, R G Dickinson, W D Hooper, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1974
Plasma protein binding of diphenylhydantoin. Effects of sex hormones, renal and hepatic disease
W D Hooper, F Bochner, M J Eadie, et al.
European Journal of Clinical Pharmacology
|
January 1, 1994
Urinary excretion of phenobarbitone and its metabolites in chronically treated patients
I Bernus, R G Dickinson, W D Hooper, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1994
Stereoselective hydroxylation of tacrine in rats and humans
W D Hooper, W F Pool, T F Woolf, et al.
British Journal of Clinical Pharmacology
|
November 1, 1994
Inhibition of phenobarbitone N-glucosidation by valproate
I Bernus, R G Dickinson, W D Hooper, et al.
European Journal of Clinical Pharmacology
|
January 1, 1994
Early stage autoinduction of carbamazepine metabolism in humans
I Bernus, R G Dickinson, W D Hooper, et al.
Page
of 11